TABLE 4.
Treatments | Serum albumin (g/dl) | Serum globulin (g/dl) | A: G | Serum total oxidative stress (μmol/L) | Serum total antioxidant capacity (mmol/L) |
G0 | 4.63 ± 0.22 | 2.59 ± 0.17B | 1.37 ± 0.05 | 17.84 ± 0.23B | 2.09 ± 0.12BC |
G1 | 3.57 ± 0.30 | 2.38 ± 0.25B | 1.17 ± 0.05 | 22.94 ± 1.56A | 1.50 ± 0.38C |
G2 | 4.21 ± 0.23 | 2.75 ± 0.11B | 1.47 ± 0.25 | 17.67 ± 1.26B | 2.74 ± 0.23AB |
G3 | 4.20 ± 0.08 | 3.37 ± 0.17A | 1.27 ± 0.05 | 16.79 ± 0.39B | 3.28 ± 0.28A |
SEM | 0.13 | 0.10 | 0.07 | 0.5966 | 0.1584 |
A–CThe values carrying different letters within column are significantly different.
G0, normal control rats; G1, acetaminophen-induced hepatotoxic rats; G2, silymarin pre-treated rats; G3, Moringa oleifera pre-treated rats.